CCT2 and colonic neoplasm: Data from our lab and others revealed that the CCT2 subunit, or CCTβ, is linked to cancer progression and increased stage/aggressiveness of breast, lung, prostate, hepatocellular, gallbladder, and colonic cancer [10–18].